3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
9
Melanoma
5
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Neoplasms
4
Neoplasm Metastasis
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Thymus Neoplasms
2
Skin Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Kidney Neoplasms
2
Glioblastoma
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Hepatectomy
10
Blood Specimen Collection
9
Sorafenib
7
Polymerase Chain Reaction
4
Biopsy
4
regorafenib
3
Mass Spectrometry
3
Liver Transplantation
3
Immunohistochemistry
3
Chemoembolization, Therapeutic
3
Walking Speed
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Magnetic Resonance Imaging
2
Gene Expression Profiling
2
Bevacizumab
2
trastuzumab deruxtecan
1
taxane
1
spartalizumab
1
sintilimab
1
lenvatinib
1
gadolinium ethoxybenzyl DTPA
1
donafenib
1
carmofur
1
camrelizumab
1
cabozantinib
1
atezolizumab
1
apatinib
1
anlotinib
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Liver Neoplasms
×
Immunotherapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled